Development and validation of an AI-based PD-L1 scoring algorithm in NSCLC samples

被引：0
|
作者：
Rodrigues, Daniela
Neppl, Christina
Dorward, David
Losmanova, Tereza
Wyatt, Rebecca
Pattle, Samuel
Oberson, Raphael
Reinhard, Stefan
Waldburger, Therese
Zlobec, Inti
Caie, Peter
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-3294
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3294
引用
收藏
页数：2
相关论文
共 50 条
  • [41] PD-L1 (SP263) staining of fine needle aspirate FFPE samples in NSCLC
    Hayden, D.
    Roland, B.
    Saufkie, K.
    Largo, S.
    Ahmadi, P.
    Vasquez, M.
    Newell, A. E. Hanlon
    Schnittker, K.
    ANNALS OF ONCOLOGY, 2020, 31 : S1113 - S1113
  • [42] Beyond inhibition against the PD-1/PD-L1 pathway: development of PD-L1 inhibitors targeting internalization and degradation of PD-L1
    Guo, Jiazheng
    Yu, Fengyi
    Zhang, Kuojun
    Jiang, Sheng
    Zhang, Xiangyu
    Wang, Tianyu
    RSC MEDICINAL CHEMISTRY, 2024, 15 (04): : 1096 - 1108
  • [43] Whole Body PD-1 and PD-L1 PET in Pts with NSCLC
    Niemeijer, A.
    Smit, E.
    Van Dongen, G.
    Windhorst, A. D.
    Huisman, M.
    Hendrikse, N.
    Bahce, I.
    Lueng, D.
    Smith, R.
    Hayes, W.
    Wilson, L.
    Bonacorsi, S.
    Donnelly, D.
    Morin, P.
    Poot, A.
    Vugts, D.
    Thunnissen, E.
    De Langen, J.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1817 - S1817
  • [44] PD-L1 expression and efficacy of pembrolizumab as monotherapy in NSCLC
    Jorgensen, Jan Trost
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (04)
  • [45] Ezrin regulates the progression of NSCLC by YAP and PD-L1
    Bu, Fan
    Zhang, Yeping
    Zhao, Ning
    Tian, Xiaoai
    Xu, Yirong
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (07): : 2239 - 2249
  • [46] Ezrin regulates the progression of NSCLC by YAP and PD-L1
    Fan Bu
    Yeping Zhang
    Ning Zhao
    Xiaoai Tian
    Yirong Xu
    Clinical and Translational Oncology, 2023, 25 : 2239 - 2249
  • [47] Heterogeneity of PD-L1 Expression and Relationship with Biology of NSCLC
    Bassanelli, Maria
    Sioletic, Stefano
    Martini, Maurizio
    Giacinti, Silvana
    Viterbo, Antonella
    Staddon, Anita
    Liberati, Fabrizio
    Ceribelli, Anna
    ANTICANCER RESEARCH, 2018, 38 (07) : 3789 - 3796
  • [48] The interaction of PD-L1, TMB, and genomic alterations in NSCLC
    Goldberg, Michael E.
    Gay, Laurie M.
    Fabrizio, David
    Frampton, Garrett M.
    Elvin, Julia A.
    Ross, Jeffrey S.
    Miller, Vincent A.
    Stephens, Philip J.
    Albacker, Lee A.
    CANCER RESEARCH, 2017, 77
  • [49] Interlaboratory-concordance of PD-L1 IHC for NSCLC
    Scheel, Andreas H.
    Banfer, Gudrun
    Baretton, Gustavo Bruno
    Dietel, Manfred
    Diezko, Rolf
    Henkel, Thomas
    Heukamp, Lukas C.
    Jasani, Bharat
    Johrens, Korinna
    Kirchner, Thomas
    Petersen, Iver
    Reu, Simone
    Schildhaus, Hans-Ulrich
    Schirmacher, Peter
    Tiemann, Markus
    Warth, Arne
    Weichert, Wilko
    Wolf, Juergen
    Ruschoff, Josef
    Buettner, Reinhard
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [50] Clinicopathologic values of PD-L1 expression and polymorphism in NSCLC
    Kim, K. -H.
    VIRCHOWS ARCHIV, 2017, 471 : S110 - S111
12345